Evidence map›Paper›PMID 42466406›Full record

ArticleResearch square2026

Development of a Combined Risk Factors Prediction Model for Esophageal Squamous Cell Carcinoma: A Secondary Analysis of the Linxian Nutrition Intervention Trial Cohort.

Huan Yang, Jingyi Shi, Jianbing Wang, Jinhu Fan, Shaokai Zhang, Yin Liu, Huifang Xu, Vikash Sewram, Jiangong Zhang, Fanghui Zhao and 2 more

Abstract readPreprint
In one paragraph

Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Huan YangCancer Hospital of Chinese Academy of Medical Sciences.
Jingyi ShiChinese Academy of Medical Sciences & Peking Union Medical College.
Jianbing WangChildren's Hospital of Zhejiang University.
Jinhu FanCancer Hospital of Chinese Academy of Medical Sciences.
Shaokai ZhangHenan Cancer Hospital.
Yin LiuHenan Cancer Hospital.
Huifang XuHenan Cancer Hospital.
Vikash SewramStellenbosch University.
Jiangong ZhangHenan Cancer Hospital.
Fanghui ZhaoCancer Hospital of Chinese Academy of Medical Sciences.
Youlin QiaoChinese Academy of Medical Sciences & Peking Union Medical College.
Christian C AbnetNational Cancer Institute.

Funding

NCI NIH HHS 75N91022C00059
6 · The paper itself

Abstract

Background: Early screening and detection is essential to reduce morbidity and mortality in esophageal cancer (EC), particularly for individuals at high risk. To reduce the burden and high costs of whole-population screening, we developed a risk score model for individualized risk assessment of esophageal squamous cell carcinoma (ESCC) incidence. Methods: The study was conducted using the Linxian Nutrition Intervention Trial cohort. Cox regression and the points system method were used to build a score-based model for ESCC risk prediction. The receiver operating characteristic (ROC) curve and calibration curve were used to examine the distinction and calibration of the models. Results: A total of 29,408 participants were included in final analysis. During the 10-year follow-up period, 1386 ESCC new cases were identified. Cox regression showed that increasing age, smoking, family history of esophageal cancer, dysphagia, fresh vegetable consumption (≤ 1 time/day), low body mass index (BMI < 18.5kg/m Conclusions: Our model effectively stratified the risk of ESCC, demonstrating a potential application in high-risk population identification and ESCC prevention.

Indexed as

Esophageal squamous cell carcinomarisk factorsrisk predictionrisk score

Identifiers

PMID42466406
PMCPMC13370643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.